SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Purespring Advances PS-003 Gene Therapy Toward Clinic

Purespring Therapeutics says it presented new preclinical and epidemiological data on PS-003 for X-linked Alport Syndrome at ASN Kidney Week 2026.

Related stories